Partner Content Partner Content SMi’s Europe’s Leading Ophthalmic Conference is only 2 weeks... Ophthalmic Drugs
News FDA approves Valeant eye drug after manufacturing delay Regulator backs potential blockbuster ophthalmology drug
Views & Analysis Learning from a successful ophthalmology brand launch Applying learnings from a successful ophthalmology brand launch to other therapy areas and pharmaceutical brands.
Partner Content Partner Content SMi’s Ophthalmic Drugs Conference is only 4 weeks away! Only 4 Weeks Remain for Ophthalmic Drugs
Partner Content Partner Content Spotlight on Key Sessions at Ophthalmic Drugs this November Sessions at Ophthalmic Drugs
News Judge throws out Allergan patents, criticises Native America... Federal court throws out patents on Restasis
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
